Close Menu

preterm birth

The firm is validating the test and expects results to be available in the second quarter of 2015 with commercial launch of the test following around mid-year.

The funding follows a $19.3 million Series A round Sera closed in 2011 and will support development of its proteomic test for assessing women's risk of preterm delivery.

Sera Prognostics said this week that it has completed enrollment of 5,500 women in its Proteomic Assessment of Preterm Risk clinical study supporting the validation of its PreTRM proteomic test for predicting risk of preterm birth.

NEW YORK (GenomeWeb News) – The Inova Translational Medicine Institute and GNS Healthcare today announced a deal to develop and commercialize computer models based on GNS' technology.

Sera Prognostics said this week that it has exceeded enrollment of 4,000 subjects in its Proteomic Assessment of Preterm Risk clinical study supporting the validation of its proteomic test for predicting risk of preterm birth.

After years of technical setbacks and challenges, mass spec-based clinical proteomics is "ready for prime time," a Thermo Fisher Scientific researcher told ProteoMonitor this week.

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with sera prognostics on the development of proteomic assays for early prediction of pregnancy complications.

By Adam Bonislawski
Proteomics in 2011 continued its long, hard slog toward the clinic, battling now-familiar challenges like sluggish test sales, unproven platforms, and the vagaries of the regulatory process.

Pages

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.